FDA Inspection 1238436 — Jiangsu Caina Medical Co., Ltd
The FDA completed an inspection of Jiangsu Caina Medical Co., Ltd on March 23, 2024 in Wuxi. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 23, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Wuxi (China)